To further elicit better predictors amongst the range of PD-L1 expression in tumor tissues, we grouped the samples based on three genetic backgrounds: sporadic cases, pseudohypoxia cluster (SDHB, VHL, EGLN1, EPAS1) and kinase signaling cluster (RET, NF1). This evidence concerns the gene EGLN1 and neoplasm.